Bio Medica Laboratories IPO — Listing Performance
Bio Medica Laboratories listed at a discount, closing its first day 16.69% below the issue price, on moderate subscription of 2.23x.
Bio Medica Laboratories IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 21-May-2026 |
| Listing date | 29-May-2026 |
| Issue size | ₹49.80 crore |
| Overall subscription | 2.23x |
| Issue price | ₹139 |
| Listing-day close | ₹115.80 (-16.69%) |
| Recent market price | ₹140.85 (1.33% vs issue) |
| Identifiers | NSE: BMLL · ISIN: INE1BKA01015 |
Figures are compiled from public market data and refreshed when our dataset updates. Verify against BSE/NSE records before acting on them.
How the listing went
Bio Medica Laboratories opened for subscription on 21-May-2026 as a SME issue raising about ₹50 crore. The shares were priced at ₹139 and made their debut on 29-May-2026, closing the first session at ₹115.80 — a listing-day change of -16.69%.
As of our last data refresh the stock trades around ₹140.85, 1.33% above the issue price.
Every IPO in our archive gets this same treatment: real issue data, the actual listing-day result, and where the price stands now — so you can judge how debut hype translated into outcomes. Compare more debuts on the IPO listing-performance archive or check live grey-market sentiment on the GMP board.
Bio Medica Laboratories IPO FAQs
What was the Bio Medica Laboratories IPO listing price?
Bio Medica Laboratories closed at ₹115.80 on its listing day (29-May-2026), against an issue price of ₹139 — a listing-day change of -16.69%.
How many times was the Bio Medica Laboratories IPO subscribed?
The issue was subscribed about 2.23 times overall.
Was the Bio Medica Laboratories IPO profitable for allottees?
Not on listing day: the stock closed about 16.69% below the issue price. Longer-term outcomes depend on when shares were sold.